SALINE, Fazirsiran
TAK-999-3002
Phase 3 small_molecule active
Quick answer
SALINE, Fazirsiran for Alpha-1 Antitrypsin Deficiency-Associated Liver Disease is a Phase 3 program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active